e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – therapy/exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic response in COPD patients with CFTR R75Q variant and mEPHX "slow" allele – is there a difference?
N. D. Petrovic, V. B. Dopudja, D. R. Ponomarev, Z. N. Slavkovic, M. M. Stankovic, A. M. Nikolic, A. I. Divac, R. P. Dragica (Belgrade, Serbia And Montenegro)
Source:
Annual Congress 2006 - COPD – therapy/exacerbations
Session:
COPD – therapy/exacerbations
Session type:
E-Posters in free access
Number:
292
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. D. Petrovic, V. B. Dopudja, D. R. Ponomarev, Z. N. Slavkovic, M. M. Stankovic, A. M. Nikolic, A. I. Divac, R. P. Dragica (Belgrade, Serbia And Montenegro). Therapeutic response in COPD patients with CFTR R75Q variant and mEPHX "slow" allele – is there a difference?. Eur Respir J 2006; 28: Suppl. 50, 292
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
High frequency of CFTR R75Q variant and mEPHX „slow" allele in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 343s
Year: 2005
Carriers of a single
CFTR
mutation are asymptomatic: an evolving dogma?
Source: Eur Respir J, 56 (3) 2002645; 10.1183/13993003.02645-2020
Year: 2020
Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C
Source: Eur Respir J 2001; 17: 1195-1200
Year: 2001
M2 allele of alpha1-antitrypsin gene and genetic susceptibility to COPD in Korean men
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation
Source: Eur Respir J 2004; 24: 1072-1073
Year: 2004
Evaluation of
MRP1-5
gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Year: 2003
Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 269-270
Year: 2014
Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 270-271
Year: 2014
Formoterol-induced downregulation of the beta2-adrenoceptor in asthmatics with homozygous glycine-16 polymorphism
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Association of C3435T polymorphism of MDR1 gene and T1808A polymorphism of NR3C1 gene with bronchial obstruction in severe asthmatics and COPD patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Evaluation of glycine allele frequency in patients with mild asthma
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Cystic Fibrosis: Clinical profile of 10 patients with R334W mutation compared to ?F508 homozigoty
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype
Source: Eur Respir J 2005; 25: 468-473
Year: 2005
Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles
Source: Eur Respir J 2004; 24 : 798-804
Year: 2004
Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
Source: Eur Respir J 2011; 37: 59-69
Year: 2011
GSTT1
null alleles are risk factors for excess FEV
1
decline in the general population, but
GSTM1
null alleles only in smokers
Source: Eur Respir J 2007; 30: Suppl. 51, 447s
Year: 2007
Lung function and disease severity in cystic fibrosis patients heterozygous for
p.Arg117His
Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016
Year: 2017
Phenotype and outcome of PAH patients carrying a TBX4 mutation
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Assessment of asthma control in asthmatic patients Brazilian carriers of the Arg16Gly polymorphism of the β2 adrenorreceptor gene
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept